Nanjing Tailaruiya E-commerce Co., Ltd – Trademark Portfolio

Entity Type: 99

Nanjing Tailaruiya E-commerce Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include YARUITK. The owner is based in Nanjing City, Jiangsu Province.

No. 1-2, Building 18, No. 289 Pusi Road, National Highway 104, Yongning Street, Pukou District,

Nanjing City, Jiangsu Province 211801 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

YARUITK
YARUITK
Registered 2025

Trademark Classifications

Nanjing Tailaruiya E-commerce Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Nanjing Tailaruiya E-commerce Co., Ltd have?

Nanjing Tailaruiya E-commerce Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Nanjing Tailaruiya E-commerce Co., Ltd file in?

Nanjing Tailaruiya E-commerce Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Nanjing Tailaruiya E-commerce Co., Ltd's most well-known trademarks?

Nanjing Tailaruiya E-commerce Co., Ltd's registered trademark portfolio includes well-known marks such as YARUITK. These are among 1 currently registered trademark in the portfolio.

What is Nanjing Tailaruiya E-commerce Co., Ltd's trademark registration success rate?

Nanjing Tailaruiya E-commerce Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.